Skip to content

The development, implementation and evaluation of a Psychosocial Intervention for patients treated for NeuroEndocrine Tumors: the PINET study

The development, implementation and evaluation of a Psychosocial Intervention for patients treated for NeuroEndocrine Tumors: the PINET study - PINET

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40080
Enrollment
180
Registered
2012-04-24
Start date
2013-03-13
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ziekte van Addison, primaire bijnier insufficientie pituitary adenoma pituitary tumor primary adrenal insufficiency

Interventions

The proposed psychosocial intervention will be based on the *Patient Education Program* (PEP)
a behavioural intervention addressing psychosocial topics. Previous research demonstrated that this program beneficially affect QoL in patients with Parkinson*s disease and their caregivers. This st
during the last session, the intervention will be evaluated. The partners/caregivers of the patients are also involved in the PEP. The participating caregivers in our study will follow the same prog

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients during follow up for pituitary tumors or Addison's disease at the outpatient clinic of the Leiden University Medical Center or the Radboud University Medical Center • Patients should be in a stable medical situation.

Exclusion criteria

Exclusion criteria: • Age 75yr • Currently receiving psychological/psychiatric treatment • Presence of psychiatric illness

Design outcomes

Primary

MeasureTime frame
Dependent variables: • Questionnaires on psychological and social aspects (QoL, illness perceptions, coping strategies, self-efficacy, personality traits) • Questionnaires about general well-being • Questionnaire about daily functioning: employment status, days absent at work due to their illness and how often they seek medical care.

Secondary

MeasureTime frame
Explorative data: • Information focus groups • Data needs assessment • Clinical data of previous treatment (including surgery, radiotherapy), • Clinical data on current status (endocrine status, substitution treatment, and concomitant disease(s) and treatment). • Data somatic screening (weight, length, blood pressure, heartbeat, hip/waist- ratio)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)